GRACE :: Lung Cancer

EGFR

Novel EGFR Inhibitors in the Setting of Acquired Resistance

Share

Acquired Resistance Forum Video #15: Dr. Pasi Jänne of Dana-Farber Cancer Institute spoke about EGFR inhibitors available to patients when Tarceva stops working for them.


Questions & Answers with Bonnie Addario and Craig Uthe; Moderated by Dr. Jack West

Share

Acquired Resistance Forum Video #14: Speakers from video #11 and video #12 at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West.


Questions & Answers with Drs. Blumenthal and Pennell; Moderated by Dr. West

Share

Acquired Resistance Forum Video #7: Speakers from videos #5 and #6 at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West.


Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations

Share

Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy.


Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era

Share

Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the US Food and Drug Administration (FDA) discussed the FDA process for approving targeted therapies.


Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Share

Immunotherapy Patient Forum 2014 Videos

 


GRACE Website Rebuild

Share

Acquired Resistance Forum Videos

 

ALK+ Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243